Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions

The coronavirus disease 2019 (COVID-19) (caused by severe acute respiratory syndrome coronavirus 2) pandemic has massively distorted our health care systems and caused catastrophic consequences in our affected communities. The number of victims continues to increase, and patients at risk can only be...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Allergy Clin Immunol
Päätekijät: Valent, Peter, Akin, Cem, Bonadonna, Patrizia, Brockow, Knut, Niedoszytko, Marek, Nedoszytko, Boguslaw, Butterfield, Joseph H., Alvarez-Twose, Ivan, Sotlar, Karl, Schwaab, Juliana, Jawhar, Mohamad, Reiter, Andreas, Castells, Mariana, Sperr, Wolfgang R., Kluin-Nelemans, Hanneke C., Hermine, Olivier, Gotlib, Jason, Zanotti, Roberta, Broesby-Olsen, Sigurd, Horny, Hans-Peter, Triggiani, Massimo, Siebenhaar, Frank, Orfao, Alberto, Metcalfe, Dean D., Arock, Michel, Hartmann, Karin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297685/
https://ncbi.nlm.nih.gov/pubmed/32561389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.06.009
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia